Skip to content

Migraine Reference

What is Migraine: A migraine is a neurological disease characterized by severe, throbbing head pain typically on one side of the head, often accompanied by nausea, vomiting, and sensitivity to light and sound. Migraine is not just a headache—it's a complex neurological condition with genetic components that affects the entire body.

Key Statistics: - Migraine is the second leading cause of global neurological disease burden - Leading cause of days lost due to disability in people under 50 years of age - One of the 10 most disabling medical disorders in the world - Affects approximately 1 billion people globally

Important Medical Note: Migraine is a legitimate, disabling neurological disease—not "just a headache" or a character flaw. People with migraine are not exaggerating their pain or seeking attention. The disability is real and measurable.


```

PREVALENCE & GENDER DIFFERENCES

Overall Prevalence

By Gender: - Women: 20.7% global prevalence - Men: 9.7% global prevalence - Women are 3-4 times more likely than men to have migraines - In the U.S.: up to 17% of women vs. 6% of men experience migraines annually

Life Course Pattern: - Before puberty: migraine prevalence similar in boys and girls - Starting at puberty: incidence increases dramatically in females - Peak prevalence: women ages 30-40 - After menopause: many women experience reduction in migraine frequency

Why Women Are More Affected

Hormonal Factors: - Fluctuations in estrogen levels (not absolute levels) trigger migraines - Drop in estrogen particularly problematic - Hormonal triggers throughout life: menstruation, pregnancy, perimenopause, menopause - About 50-60% of women with migraine experience menstrual migraines

Biological Factors: - Genetic predisposition - Differences in pain processing between sexes - Hormonal influence on brain chemistry and blood vessels - Higher prevalence of comorbid conditions in women (anxiety, depression)

Migraine in Men

Underdiagnosis Problem: - Migraine often underdiagnosed in men - Perceived primarily as "women's health issue" - Results in suboptimal management and less research participation - Men less likely to seek medical support for migraines

How Symptoms Differ in Men: - Men often exhibit atypical symptoms compared to diagnostic criteria - Less likely to report classic associated symptoms (nausea, light sensitivity) - More likely to report physical health comorbidities (obesity) - Fewer psychological comorbidities than women - Tend to respond more favorably to pharmacological treatments when diagnosed

Testosterone Connection: - Men with chronic migraine have significantly lower testosterone levels (mean 322 ng/dL, in lower 5% of reference range) - Many men with chronic migraine exhibit hypogonadism symptoms: depressed mood, reduced energy, difficulty concentrating - Men with migraine show lower testosterone to estrogen ratio (3.9) compared to men without migraine (5.0) - 61% of men with migraine report symptoms of relative testosterone deficiency (mood, energy, sexual disorders) vs. 27% without migraine - Research suggests testosterone supplementation may reduce migraine frequency in men


TYPES OF MIGRAINE

Migraine Without Aura (Most Common)

Characteristics: - About 75% of people with migraine - No warning signs before headache begins - Throbbing, pulsing pain (usually one-sided) - Moderate to severe intensity - Lasts 4-72 hours if untreated - Worsened by routine physical activity

Associated Symptoms: - Nausea and/or vomiting - Sensitivity to light (photophobia) - Sensitivity to sound (phonophobia) - Sensitivity to smells

Migraine With Aura (About 25%)

What is Aura: - Series of sensory disturbances or disruptions to language - Usually happens 5-60 minutes before headache phase - Acts as warning sign - Can occur without subsequent headache (silent migraine)

Types of Aura:

Visual Aura (Most Common): - Flashing lights, zigzags, blind spots - Shimmering or wavy vision - Tunnel vision - Seeing geometric patterns - Temporary vision loss

Sensorimotor Aura: - Tingling or numbness (often starts in hand, spreads to arm/face) - Pins and needles sensation - Weakness on one side of body - Can mimic stroke symptoms

Dysphasic Aura (Least Common): - Difficulty speaking or understanding language - Slurred speech or mumbling - Inability to find words - Verbal confusion

Important Note: Sensorimotor aura or dysphasic aura can be terrifying and may be mistaken for stroke. However, migraine aura typically develops gradually over 5+ minutes, while stroke symptoms are sudden.

Chronic Migraine vs. Episodic Migraine

Episodic Migraine: - Fewer than 15 headache days per month - May have predictable triggers - Most people with migraine have episodic form

Chronic Migraine (More Severe): - 15 or more headache days per month - At least 8 days per month with migraine features - Must persist for at least 3 months - Can evolve from episodic migraine - More disabling, harder to treat - Significantly impacts daily functioning

Other Types

Menstrual Migraine: - Occurs in the 2 days before period and first 3 days of flow - Related to estrogen drop - Often more severe and harder to treat - May be "pure" menstrual (only with period) or "menstrually-related" (also at other times)

Hemiplegic Migraine (Rare and Serious):

Overview: - Rare subtype of migraine with aura - Includes temporary paralysis or weakness (hemiplegia) on one side of body - Symptoms mimic stroke so closely that differential diagnosis is critical - Strong genetic component (familial hemiplegic migraine) - Can also occur sporadically (sporadic hemiplegic migraine) - Requires specialized treatment and specific medication contraindications

Symptoms During Attack: - Motor weakness on one side of body (temporary paralysis) - Typically affects arm and leg on same side - Facial weakness, drooping - Slurred speech or difficulty speaking - Visual disturbances (typical migraine aura) - Severe, throbbing headache (usually follows motor symptoms) - Numbness or tingling on affected side - Confusion or altered consciousness (in some cases) - Symptoms can last hours to days

Why It's Often Misdiagnosed: - Symptoms are identical to stroke presentation - Left-sided weakness + slurred speech = classic stroke symptoms - Without proper neurological workup and history, easily mistaken for TIA (transient ischemic attack) - First episode especially likely to be treated as stroke emergency - Many emergency departments not familiar with hemiplegic migraine - Requires ruling out actual stroke through imaging and examination - Complete recovery between episodes suggests migraine, not stroke damage

Critical Distinction from Stroke: - Hemiplegic migraine: Symptoms develop gradually over 5-60 minutes - Stroke: Symptoms are sudden and immediate - Hemiplegic migraine: Complete recovery after episode - Stroke: Often leaves lasting damage - Hemiplegic migraine: Pattern of recurrent episodes - Stroke: Typically single events (or multiple with risk factors)

Triggers: - Stress (major trigger for many patients) - Physical exertion - Emotional stress - Minor head trauma - Certain foods (individual triggers) - Changes in sleep patterns - Hormonal changes

Diagnosis Challenges: - Requires neurological consultation - MRI/CT during attack may show changes but are reversible - Between attacks, imaging typically normal - Diagnosis based on clinical history and exclusion of stroke - Family history helpful if present - Many patients go years or decades without proper diagnosis - Often dismissed as "just stress" or "in your head"

Treatment Considerations: - TRIPTANS CONTRAINDICATED (can worsen symptoms, risk of prolonged aura) - ERGOTAMINES CONTRAINDICATED - Treatment focuses on prevention rather than acute management - Preventive medications similar to other migraine types (beta-blockers, calcium channel blockers, antiepileptics) - Acute treatment limited to NSAIDs, anti-nausea medications - Avoiding triggers crucial - Genetic counseling if familial type - Careful monitoring for actual stroke risk (some types carry increased risk)

Long-term Misdiagnosis Impact: - Decades of episodes without proper treatment - Psychological impact of being told "it's in your head" - Medical gaslighting if symptoms dismissed - Delayed access to preventive treatments - Unnecessary fear of stroke with each episode - Impact on quality of life, work, relationships - Self-doubt about own experience

Case Example: Tommy Hayes - First episode age 15 (1969) - Recurrent episodes throughout life (28 years undiagnosed) - Left-sided weakness, slurred speech, severe headache - Episodes triggered by stress - Partner dismissed symptoms as "dramatics" for 20 years - Medical gaslighting: "It's all in your head," "Just take aspirin" - Stopped seeking medical help, managed with OTC medications - Internalized belief he was "weak" - Finally diagnosed age 43 (March 1997) after severe episode - Misdiagnosed as possible stroke initially - Proper neurological workup revealed hemiplegic migraine - Treatment with preventive medications significantly improved quality of life - 28 years of unnecessary suffering due to lack of diagnosis

Why Proper Diagnosis Matters: - Access to appropriate preventive treatments - Avoiding contraindicated medications (triptans) - Validation of patient's experience - Understanding of triggers and patterns - Reduced anxiety about stroke - Proper emergency care protocols - Family members can be screened if genetic type - Quality of life improvement with management

Vestibular Migraine: - Includes dizziness, vertigo, balance problems - May or may not include headache - Often misdiagnosed as inner ear problem

Silent Migraine: - Aura without subsequent headache - All other migraine symptoms may be present - Still requires treatment


MIGRAINE PHASES

Prodrome Phase (Warning Phase)

Timing: Begins up to 24 hours before headache

Symptoms May Include: - Mood changes (irritability, depression, euphoria) - Food cravings (especially salt or carbohydrates) - Increased thirst and urination - Neck stiffness - Yawning frequently - Difficulty concentrating - Sensitivity to light or sound - Fatigue or excess energy

Important: Not everyone experiences prodrome, and many people don't recognize these as warning signs until they learn to track patterns.

Aura Phase (If Present)

Timing: 5-60 minutes before or during headache

Characteristics: - Visual, sensory, motor, or language disturbances - Usually develops gradually - Typically reversible - Can be frightening, especially first time

Headache Phase (Attack)

Timing: 4-72 hours if untreated

Pain Characteristics: - Throbbing, pulsing, or pounding quality - Usually one-sided (but can be bilateral) - Moderate to severe intensity - Worsened by routine physical activity (walking, climbing stairs)

Associated Symptoms: - Nausea and/or vomiting - Sensitivity to light (need dark room) - Sensitivity to sound (need quiet) - Sensitivity to smells - Dizziness or lightheadedness - Blurred vision - Cognitive difficulties ("brain fog")

Important: The pain is not just severe—it's disabling. During an attack, many people cannot function and need to lie down in a dark, quiet room.

Postdrome Phase ("Migraine Hangover")

Timing: Can last 24-48 hours after headache resolves

Symptoms: - Exhaustion and fatigue - Difficulty concentrating - Mood changes (often depressed or euphoric) - Weakness - Dizziness - Sensitivity to light and sound (lingering) - Body aches

Important: The postdrome phase is often overlooked but can be severely disabling. People may need rest and recovery time even after the headache ends.


COMMON TRIGGERS

Important Note: Triggers are highly individual. What triggers one person's migraine may not affect another. Tracking patterns is essential.

Hormonal Triggers (Especially Women)

Menstruation: - Drop in estrogen 2 days before and during first 3 days of period - Most common hormonal trigger

Pregnancy: - 50-80% of women experience reduction in migraines during pregnancy (especially 2nd and 3rd trimesters) - First trimester can be difficult (hormonal fluctuations) - Postpartum period can trigger migraines (estrogen drop)

Perimenopause: - Unpredictable hormone fluctuations - Many women experience worsening migraines during perimenopause - Erratic periods make patterns harder to predict

Menopause: - Many women experience improvement after menopause - Stable hormone levels can reduce migraine frequency - Some women's migraines worsen

Hormonal Contraception: - Birth control pills can help or worsen migraines (individual response) - Continuous dosing (skipping placebo week) may help menstrual migraines - Estrogen-containing contraceptives contraindicated for migraine with aura (stroke risk)

Food and Drink Triggers

Common Food Triggers: - Aged cheeses (tyramine) - Processed meats (nitrates/nitrites) - MSG (monosodium glutamate) - Artificial sweeteners (especially aspartame) - Chocolate (controversial—may be craving during prodrome rather than trigger) - Citrus fruits - Foods with histamine

Beverages: - Alcohol (especially red wine, beer) - Too much caffeine - Caffeine withdrawal (missing usual morning coffee) - Not drinking enough water (dehydration)

Dietary Patterns: - Skipping meals (blood sugar drop) - Irregular eating schedule - Not eating enough - Fasting

Environmental Triggers

Sensory Overload: - Bright lights or flashing lights - Fluorescent lighting - Loud noises - Strong smells (perfume, cigarette smoke, cleaning products, gasoline) - Weather changes (barometric pressure, humidity)

Physical Environment: - High altitude - Extreme heat or cold - Stuffy or poorly ventilated rooms

Sleep and Routine

Sleep Disruptions: - Too little sleep - Too much sleep (sleeping in on weekends) - Irregular sleep schedule - Sleep disorders (sleep apnea, insomnia) - Jet lag

Routine Changes: - Change in daily schedule - Travel - Time zone changes - Weekends or vacations (let-down after stress)

Physical and Lifestyle Factors

Physical Exertion: - Intense exercise (especially if not warmed up) - Sexual activity - Physical overexertion

Stress: - Acute stress - Chronic stress - "Let-down" after stressful period (weekend migraines) - Anxiety

Other Physical Factors: - Eyestrain - Neck tension or poor posture - Jaw clenching or TMJ - Head injury or concussion

Medications

Medication Overuse: - Taking acute migraine medications too frequently (more than 10-15 days per month) - Can lead to medication overuse headache (rebound headache) - Creates vicious cycle

Other Medications: - Oral contraceptives (individual response) - Vasodilators - Some blood pressure medications - Hormone replacement therapy


SYMPTOM DIFFERENCES: MEN VS. WOMEN

Women's Experience

More Severe Presentation: - Migraines more frequent - Longer-lasting attacks - More disabling - Greater migraine-related disability (34% lose work/school time vs. 25% of men)

Typical Symptoms More Common: - Nausea and vomiting - Sensitivity to light - Sensitivity to sound - Sensitivity to touch/heightened tactile sensitivity - More likely to experience all classic associated symptoms

Psychological Comorbidities Higher: - Anxiety disorders significantly more common - Depression rates higher (47-50% have major depressive disorder) - Panic disorder - Generalized anxiety disorder

Healthcare-Seeking: - More likely to visit emergency department for severe migraine - More likely to seek medical treatment overall - More likely to try multiple treatments

Men's Experience

Atypical Presentation: - Often don't meet ICHD-3 (International Classification of Headache Disorders) criteria exactly - Less likely to report classic associated symptoms - May present differently, leading to underdiagnosis

Physical Comorbidities More Common: - Obesity more prevalent - Cardiovascular issues - Metabolic syndrome

Psychological Comorbidities Lower: - Fewer anxiety disorders than women with migraine - Lower rates of depression than women with migraine - But still higher than men without migraine

Healthcare-Seeking: - Less likely to seek medical support - May minimize or dismiss symptoms - Social expectations around "toughing it out" - Often diagnosed later, if at all

Treatment Response: - Tend to respond more favorably to pharmacological treatments (when diagnosed) - May have fewer treatment failures - But less likely to be prescribed preventive treatments due to underdiagnosis

Hormonal Factors: - Low testosterone associated with chronic migraine in men - Testosterone supplementation may be helpful - Less research on hormonal aspects of migraine in men


DISABILITY AND IMPACT

Work and School

Absenteeism: - Migraine is leading cause of days lost due to disability in people under 50 - People with more than 15 headache days per month are 3 times more likely to report disability-related unemployment - Missed workdays, missed school days - Impact on career advancement and educational achievement

Presenteeism: - Working or attending school while impaired - Productivity reduced by half or more during migraine - Difficulty concentrating, completing tasks - Making errors, needing extra time - Cognitive impairment ("brain fog")

MIDAS Score: - Migraine Disability Assessment Scale - Quantifies absenteeism and reduced productivity - Used to determine treatment approaches

Social and Family Impact

Social Functioning: - Cancelled plans, missed events - Strain on relationships (friends, romantic partners, family) - Feeling unreliable or letting others down - Social isolation due to unpredictability

Family Responsibilities: - Difficulty caring for children during attacks - Missed family events - Burden on partners/family members - Guilt about impact on loved ones

Recreational Activities: - Abandoned hobbies and leisure activities - Fear of triggering migraine limits participation - Loss of enjoyment in previously loved activities

Quality of Life

Physical Impact: - Pain and suffering during attacks - Postdrome exhaustion - Fear of next attack (anticipatory anxiety) - Sleep disturbances

Emotional Impact: - Depression (47-50% prevalence in migraine patients) - Anxiety (2-5 times more common than general population) - Frustration, anger, helplessness - Reduced self-esteem - Grief over lost functioning

Cognitive Impact: - "Brain fog" during and after attacks - Difficulty concentrating - Memory problems - Difficulty with complex tasks - Slowed processing speed

Financial Impact: - Medical costs (appointments, medications, ER visits) - Lost wages due to missed work - Reduced earning potential - Disability claims - Cost of employer accommodations

Relationships and Intimacy

Romantic Relationships: - Sexual activity can trigger migraine for some - Difficulty maintaining intimacy during frequent attacks - Partners may not understand invisible disability - Strain from cancelled plans, changed schedules - Resentment or guilt on both sides

Stigma and Disbelief: - "It's just a headache" dismissal - Accusations of exaggerating or seeking attention - Perceived as unreliable or lazy - Pressure to "push through" or "get over it" - Lack of understanding from employers, friends, family


COMORBIDITIES

Important Note: Comorbidity means these conditions occur together more frequently than chance. It doesn't mean one causes the other, but they may share underlying mechanisms.

Psychiatric Comorbidities

Depression: - 47-50% of people with migraine have major depressive disorder - Bidirectional relationship (each increases risk of the other) - Shared neurobiological mechanisms - Depression can worsen migraine frequency and severity - Treating depression can improve migraine outcomes

Anxiety Disorders: - 2-5 times more common in people with migraine - Generalized anxiety disorder (GAD) most common - Panic disorder (10-fold increased likelihood) - Social anxiety - Anxiety can trigger migraines; migraines can cause anxiety

Bipolar Disorder: - Higher prevalence in people with migraine - Some migraine medications (valproate, topiramate) also treat bipolar disorder - Shared genetic factors

Cardiovascular Comorbidities

Stroke Risk: - Migraine with aura associated with increased stroke risk - Relative risk: 1.56-2.41 for migraine with aura - Relative risk: 1.11-1.83 for migraine without aura - Risk higher in women, smokers, those on estrogen contraception - 2021 European Society of Cardiology guidelines recommend considering migraine with aura in cardiovascular risk assessment

Other Cardiovascular Issues: - Increased risk of atrial fibrillation - Increased risk of myocardial infarction - Increased cardiovascular death compared to those without migraine - Depression and anxiety may compound cardiovascular risk - Inflammation and endothelial dysfunction as possible shared mechanisms

Important: Risk is still relatively low overall. Not everyone with migraine will have cardiovascular events. But awareness and risk modification important.

Other Neurological Conditions

Epilepsy: - Higher prevalence in people with migraine - Shared mechanisms (cortical spreading depression) - Some medications treat both conditions

Stroke: - As above, increased risk especially with aura

Vertigo/Vestibular Disorders: - Vestibular migraine common - Dizziness, vertigo, balance problems

Sleep Disorders

Insomnia: - Very common in people with migraine - Bidirectional relationship - Poor sleep can trigger migraines - Migraines can disrupt sleep

Sleep Apnea: - Higher prevalence in people with migraine - Treating sleep apnea can reduce migraine frequency

Other Sleep Issues: - Restless leg syndrome - Circadian rhythm disorders

Chronic Pain Conditions

Fibromyalgia: - Often co-occurs with migraine - Shared pain processing abnormalities - Central sensitization

Chronic Back/Neck Pain: - Neck pain very common in migraine - Tension-type headache often coexists

Temporomandibular Joint Disorder (TMJ): - Jaw clenching can trigger migraines - Shared pain pathways

Gastrointestinal Conditions

Irritable Bowel Syndrome (IBS): - Higher prevalence in people with migraine - Shared neural pathways (gut-brain axis)

Cyclic Vomiting Syndrome: - Particularly in children - May be migraine variant

Metabolic and Endocrine

Obesity: - Associated with increased migraine frequency - More common comorbidity in men with migraine

Hypothyroidism: - Can coexist with migraine - Treating thyroid issues may help migraine

Diabetes: - Some associations with migraine prevalence

Allergies and Immune

Allergies: - Seasonal allergies common in people with migraine - May share histamine pathways

Asthma: - Higher prevalence in migraine patients


DIAGNOSIS

Clinical Diagnosis

Important: Migraine is diagnosed clinically based on history and symptoms. There is no blood test, scan, or other objective test that confirms migraine.

ICHD-3 Criteria (International Classification of Headache Disorders, 3rd edition):

Migraine Without Aura: - At least 5 attacks fulfilling criteria - Headache lasting 4-72 hours (untreated) - At least 2 of the following: - Unilateral location - Pulsating quality - Moderate or severe intensity - Aggravation by routine physical activity - During headache, at least 1 of: - Nausea and/or vomiting - Photophobia and phonophobia - Not better accounted for by another diagnosis

Migraine With Aura: - At least 2 attacks fulfilling criteria - At least 1 fully reversible aura symptom - At least 3 of the following: - At least 1 aura symptom spreads gradually over 5+ minutes - Two or more aura symptoms occur in succession - Each aura symptom lasts 5-60 minutes - At least 1 aura symptom is unilateral - At least 1 aura symptom is positive (visual phenomena, pins and needles) - Aura accompanied or followed within 60 minutes by headache - Not better accounted for by another diagnosis

Differential Diagnosis

Conditions That May Be Mistaken for Migraine: - Tension-type headache - Cluster headache - Sinus headache (often is actually migraine) - Medication overuse headache (can coexist with migraine) - Secondary headaches (from underlying condition)

Red Flags Requiring Further Investigation: - "Thunderclap" headache (sudden, severe) - First or worst headache of life - Headache with fever, stiff neck, confusion - Headache after head injury - Headache with neurological symptoms that don't fit migraine pattern - Headache that is always on same side (may indicate structural issue) - New headache in person over 50 - Significant change in headache pattern

Diagnostic Tools

Headache Diary: - Track frequency, duration, intensity - Note triggers, symptoms, treatments used - Essential for diagnosis and treatment planning

MIDAS (Migraine Disability Assessment): - Quantifies disability - Guides treatment intensity

HIT-6 (Headache Impact Test): - Measures impact on daily life - Used to assess treatment effectiveness

Imaging (CT, MRI): - NOT routine for migraine diagnosis - Used only if red flags present - To rule out other causes (tumor, aneurysm, structural abnormalities) - Normal imaging does NOT rule out migraine


TREATMENT

Acute Treatment (Abortive)

Goal: Stop migraine attack once it starts

Triptans (Most Common): - Sumatriptan, rizatriptan, eletriptan, others - Work by constricting blood vessels and blocking pain pathways - Most effective when taken early in attack - Available in various forms: pills, nasal spray, injection - Contraindicated in cardiovascular disease, uncontrolled hypertension - Contraindicated in hemiplegic migraine - Can cause medication overuse headache if used too frequently (>10 days/month)

NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): - Ibuprofen, naproxen, aspirin - Can be effective for mild to moderate migraine - Best taken early - Risk of gastrointestinal side effects with frequent use - Can cause medication overuse headache if used too frequently (>15 days/month)

Gepants (Newer Class): - Ubrogepant, rimegepant - CGRP receptor antagonists - Alternative for those who can't take triptans - Can be used for prevention as well

Ditans: - Lasmiditan - Serotonin receptor agonist (different mechanism than triptans) - Option for those with cardiovascular contraindications to triptans

Anti-Nausea Medications: - Metoclopramide, prochlorperazine, ondansetron - Treat nausea/vomiting - Some have independent pain-relieving effects - Often given with other acute treatments

Combination Medications: - Excedrin Migraine (acetaminophen, aspirin, caffeine) - May be effective for mild migraine - Risk of medication overuse headache

Ergotamines (Older Class): - Ergotamine, dihydroergotamine (DHE) - Less commonly used now (triptans more effective, better side effect profile) - DHE available as nasal spray or injection

Other Acute Treatments: - Corticosteroids (for status migrainosus—prolonged migraine) - Intravenous fluids (for dehydration) - Nerve blocks (occipital nerve blocks, sphenopalatine ganglion blocks)

Preventive Treatment (Prophylactic)

Goal: Reduce frequency, severity, and duration of attacks

When to Consider Prevention: - 4 or more migraine days per month - Attacks significantly interfere with daily life - Acute medications not effective or contraindicated - Medication overuse headache - Patient preference

Beta-Blockers: - Propranolol, metoprolol - First-line prevention - Lower blood pressure, slow heart rate - Contraindicated in asthma, certain heart conditions

Antiepileptic Drugs: - Topiramate, valproate - Effective for prevention - Side effects can be significant (cognitive slowing, weight changes, birth defects) - Valproate generally avoided in women of childbearing potential

Antidepressants: - Amitriptyline, venlafaxine - Can help migraine and comorbid depression/anxiety - Sedating (often taken at night)

Calcium Channel Blockers: - Verapamil - Used for prevention, especially in certain types

CGRP Monoclonal Antibodies (Newer, Highly Effective): - Erenumab, fremanezumab, galcanezumab, eptinezumab - Target CGRP (calcitonin gene-related peptide) pathway - Given by injection (monthly or quarterly) or IV infusion - Specifically developed for migraine prevention - Fewer side effects than older preventives - Expensive but often covered by insurance

Botox (OnabotulinumtoxinA): - FDA-approved for chronic migraine (15+ headache days/month) - Injections every 12 weeks - Typically 31 injections in head and neck - Can take 2-3 treatment cycles to see full effect

Supplements (Evidence Varies): - Magnesium (400-500mg daily) - Riboflavin/Vitamin B2 (400mg daily) - Coenzyme Q10 (CoQ10) - Feverfew - Butterbur (safety concerns with liver toxicity)

Devices: - Cefaly (external trigeminal nerve stimulation) - GammaCore (vagus nerve stimulation) - Nerivio (remote electrical neuromodulation) - SpringTMS (transcranial magnetic stimulation) - FDA-approved for some patients, alternatives to medication

Treatment for Menstrual Migraine

Mini-Prevention: - Taking NSAIDs, triptans, or gepants starting 2 days before expected period - Continuing through first few days of menstruation - "Frovatriptan protocol" (triptan taken perimenstrually)

Estrogen Supplementation: - Estrogen gel or patch during expected drop in estrogen - Maintains estrogen levels, prevents migraine trigger - Must be prescribed and monitored

Continuous Hormonal Contraception: - Skipping placebo week to avoid estrogen drop - Can reduce menstrual migraines - Requires discussion with gynecologist

Standard Preventive Medications: - Same as above, taken continuously

Treatment During Pregnancy and Breastfeeding

Important: Many migraine medications are NOT safe during pregnancy.

Safe Acute Options: - Acetaminophen (Tylenol) - Some NSAIDs (ibuprofen in 2nd trimester only, not 1st or 3rd) - Nerve blocks (occipital) - Some anti-nausea medications

Generally Avoided: - Triptans (category C, limited data) - Ergotamines (contraindicated) - NSAIDs in 1st and 3rd trimesters - Most preventive medications

Good News: - 50-80% of women experience improvement during pregnancy - Especially in 2nd and 3rd trimesters - Non-medication management becomes crucial

Breastfeeding: - Some medications compatible with breastfeeding - Requires individual discussion with doctor - Timing of doses around feeding schedule

Lifestyle and Non-Medication Management

Sleep Hygiene: - Consistent sleep schedule (even weekends) - 7-9 hours per night - Dark, cool, quiet bedroom - No screens before bed - Treating sleep disorders if present

Dietary Management: - Regular meals (don't skip) - Identify and avoid personal triggers - Adequate hydration - Limiting alcohol - Limiting caffeine (or keeping consistent intake)

Stress Management: - Relaxation techniques - Mindfulness and meditation - Yoga - Deep breathing exercises - Pacing activities (avoiding overcommitment)

Exercise: - Regular aerobic exercise (30 min, 3-5x/week) - Gradual warm-up (avoid sudden intense exertion) - Swimming, walking, cycling often well-tolerated - Yoga, tai chi

Biofeedback: - Learning to control physiological responses - Evidence-based for migraine - No side effects - Can be combined with medications

Cognitive Behavioral Therapy (CBT): - Addresses thoughts and behaviors around pain - Helps with comorbid anxiety and depression - Improves coping strategies - Evidence-based for chronic pain conditions including migraine

Trigger Avoidance: - Identifying personal triggers through diary - Avoiding known triggers when possible - Managing unavoidable triggers (weather, hormones) proactively

Devices and Alternative Approaches: - Cefaly, GammaCore, Nerivio (as above) - Acupuncture (some evidence for prevention) - Massage therapy (especially for neck tension) - Physical therapy (for cervicogenic component)

Emergency Treatment

When to Go to ER: - Status migrainosus (migraine lasting >72 hours) - Intractable vomiting leading to dehydration - First or worst headache of life - Headache with fever, stiff neck, confusion, weakness - Thunderclap headache (sudden, severe) - Any red flag symptoms

ER Treatments: - IV fluids for dehydration - IV anti-nausea medications - IV NSAIDs (ketorolac) - IV magnesium - Nerve blocks - IV corticosteroids - DHE protocol (dihydroergotamine) - Observation and monitoring

Important: ERs should NOT give opioids for migraine (not effective, risk of medication overuse). If ER offers opioids, patient can request migraine-specific treatment instead.


MEDICATION OVERUSE HEADACHE (MOH)

What It Is

Definition: - Headache that develops or worsens with frequent use of acute headache medications - Also called "rebound headache" - Creates vicious cycle: headache → take medication → headache returns → take more medication

Diagnostic Criteria: - Headache 15+ days per month - Regular overuse of acute medications for >3 months: - Triptans, ergotamines, opioids, combination medications: >10 days/month - Simple analgesics (NSAIDs, acetaminophen): >15 days/month - Headache developed or worsened during medication overuse

How It Develops

The Cycle: 1. Person has migraines, takes acute medication (appropriate) 2. Medications work well initially 3. Over time, takes medication more frequently (treating more days per month) 4. Exceeds safe threshold (10 or 15 days/month depending on medication) 5. Develops daily or near-daily headache 6. Headache pattern changes: less severe but more constant 7. Medications become less effective 8. Takes more medication to get relief 9. Cycle continues

Risk Factors: - Having frequent migraines to begin with - Anxiety or depression - Stress - Other chronic pain conditions - History of substance use - Not using preventive medications

Recognition

Symptoms: - Headache most days (15+ days/month) - Dull, constant headache (different from usual migraine) - Awakens with headache - Worse in morning - Medications less effective - Need increasing doses or frequency - Headache returns as medication wears off

Pattern: - Using acute medications >10-15 days per month - Taking medication to prevent headache (not just treat active one) - Taking medication at first sign of mild headache (before it develops) - Anxiety about running out of medication

Treatment

Withdrawal: - Stop overused medication (under medical supervision) - Withdrawal period typically 2-4 weeks - May experience worsening headache initially ("withdrawal headache") - Can be done outpatient or inpatient depending on severity

During Withdrawal: - Start or optimize preventive medication - Bridge therapy (short-term medication to get through withdrawal) - Anti-nausea medications - Corticosteroids (short course) - Fluids, rest

After Withdrawal: - Continue preventive medication - Limit acute medication to 2 days per week (8-10 days per month maximum) - Use most effective acute treatment (don't save "strong" medication for later) - Treat early in attack (don't wait for headache to worsen) - Track medication use in diary

Prevention of MOH: - Use acute medications appropriately (no more than 10-15 days/month) - Use preventive medication if having frequent migraines - Address anxiety and depression - Don't "save" medication for later - Track usage in headache diary


LIVING WITH MIGRAINE

Self-Advocacy

At Medical Appointments: - Bring headache diary with detailed tracking - Describe impact on daily life, not just pain level - Be specific about symptoms - Don't minimize or downplay disability - Ask about preventive options - Discuss goals for treatment

With Employers/Schools: - Migraine is covered under ADA (Americans with Disabilities Act) if sufficiently disabling - Possible accommodations: - Flexible schedule - Work from home options - Dim lighting or location away from fluorescent lights - Quiet workspace - Breaks as needed - Modified duties during postdrome - Don't need to disclose unless requesting accommodations - Document communications

With Family and Friends: - Educate about migraine (not just a headache) - Explain unpredictability - Set realistic expectations - Ask for specific support - Let them know how they can help during attack

Practical Strategies

Planning and Pacing: - Don't overcommit schedule - Build in rest time - Plan for recovery time after big events - Have backup plans for important events - Keep rescue medications accessible

Environmental Modifications: - Wear sunglasses (even indoors if needed) - Use blue light filters on screens - Control lighting at home and work - Keep temperature comfortable - Minimize exposure to triggers (scents, noise)

Medication Management: - Keep medications in multiple locations (home, work, car, purse) - Don't wait until headache is severe to treat - Track usage to avoid medication overuse - Have plan for prescription refills (don't run out) - Keep list of all medications (including preventives)

Communication During Attack: - Let family know you're having migraine - Use simple signals ("migraine" or "need quiet") - Text instead of talking if phone use needed - Don't feel guilty about needing rest - Explain what helps (dark room, ice pack, quiet)

Emotional Health

Coping with Chronic Illness: - Acknowledge grief over lost functioning - Seek therapy if needed (CBT, acceptance and commitment therapy) - Join support groups (in-person or online) - Connect with others who understand - Practice self-compassion

Managing Anxiety: - Fear of next attack is common - Mindfulness and relaxation techniques - Therapy for health anxiety - Focus on what can be controlled (triggers, treatment) - Distinguish between anxiety and prodrome symptoms

Addressing Depression: - Common comorbidity, should be treated - Antidepressants may help both migraine and depression - Therapy alongside medication - Don't suffer in silence - Depression is not weakness or character flaw

Relationships and Social Life

Communicating Needs: - Be direct about limitations - Explain unpredictability - Set boundaries around triggers - Don't apologize for having migraine - Educate partners, family, friends

Maintaining Connections: - Quality over quantity in social plans - Choose low-trigger activities when possible - Have plan B for cancelled plans - Video calls instead of in-person if needed - Be honest about capacity

Intimacy: - Discuss triggers with partner (if sex is trigger) - Plan around predictable migraine patterns (menstrual) - Communicate during attacks - Find ways to connect that don't trigger migraine - Partner education crucial


CHARACTER-SPECIFIC EXPERIENCES IN FAULTLINES SERIES

Jacob Keller - Chronic Migraine with Severe Disability

Character: Dr. Jacob Nathaniel Keller (concert pianist, b. 2007)

Migraine Pattern: - Frequency: 15-20 migraine days per month (chronic migraine) - Severity: 6-10 of those days include vomiting severe enough to require emergency room visits for IV fluids - Type: Migraine without aura (most common presentation) - Duration: Episodes last 4-72 hours if untreated, with severe cases requiring hospitalization

Clinical Significance: Jacob's migraine frequency places him firmly in the "chronic migraine" category (15+ headache days per month). This level of disability means he loses approximately half his days each month to migraine attacks, with one-third to half of those attacks being severe enough to require emergency medical intervention for dehydration due to intractable vomiting.

Impact on Daily Functioning: - Professional Life: Concert pianist career significantly affected by unpredictable severe attacks - Parenting: Daughter Clara learned from young age to recognize migraine warning signs and help manage attacks - Medical Management: Requires ongoing preventive treatment, acute medications, and frequent ER visits - Disability Status: This frequency represents significant neurological disability requiring accommodations

Typical Attack Pattern for Jacob: During severe migraine attacks, Jacob experiences: - Throbbing, pulsing pain (usually one-sided) - Severe nausea and vomiting (requiring IV fluids 6-10 times per month) - Extreme photophobia (light sensitivity) - requires dark room - Extreme phonophobia (sound sensitivity) - requires silence - Movement worsens pain - must lie still - Post-attack exhaustion (postdrome phase lasting 24-48 hours)

Relationship to Other Conditions: Jacob's chronic migraine exists alongside: - Cluster headaches (developed mid-thirties) - distinct condition requiring different management - Epilepsy (seizure disorder) - comorbidity common in migraine patients - Bipolar I disorder - comorbidity common in migraine patients - Autism spectrum - sensory sensitivities may interact with migraine triggers - ADHD - shared neurological factors - Chronic pain conditions

Management Complexity: Managing Jacob's migraines is complicated by: - Multiple comorbid conditions requiring medication interactions to be carefully considered - Sensory sensitivities from autism making environmental triggers more impactful - Seizure disorder limiting some medication options - Bipolar disorder requiring mood stabilizers that may interact with migraine treatments - Need for both preventive and acute treatments - Frequent ER visits for severe attacks requiring IV intervention

Family Impact: Clara Keller (daughter) has been deeply affected by growing up with a parent with chronic migraine: - Learned to recognize prodrome signs and warning symptoms - Knows emergency protocols for severe attacks - Understands the difference between migraines and cluster headaches - Manages household during attacks (age-appropriate involvement, not parentification) - Developed medical literacy and competence through necessity - Experiences her own anxiety about her father's health during severe attacks

Representation Significance: Jacob's chronic migraine portrayal demonstrates: - Migraine as legitimate, disabling neurological disease (not "just a headache") - How chronic pain conditions affect parenting and family dynamics - The reality of invisible disability (looks fine between attacks) - Medical complexity when multiple conditions coexist - How children of chronically ill parents develop caregiving competencies - The unpredictability and lost time that characterizes severe chronic migraine - That disability doesn't equal inability - Jacob maintains his career and devoted parenting despite severe limitations

Logan Weston - Stress-Induced Migraines

Character: Dr. Logan Matthew Weston (neurologist, pain specialist, b. September 28, 2007)

Migraine Pattern: - Type: Stress-induced migraines with prominent nausea and vomiting - Onset: First became clinically significant during his first semester at Howard University in fall 2025, when academic pressure, chronic sleep deprivation, and emotional crisis created conditions for frequent attacks - Frequency: Episodic, escalating under sustained stress; became more pronounced during finals week (December 2025) when multiple stressors converged

Stress-Related Triggers: Logan's migraines are closely tied to the "Weston Double" pattern that defined his academic career—brilliant performance followed by physical collapse. During his first semester at Howard, the triggers included an unsustainably heavy course load, a neuroanatomy study group with upperclassmen, the pressure of a co-authorship offer from Dr. Harrison on an epigenetics paper, chronic sleep deprivation, erratic blood sugar management as stress wreaked havoc on his Type 1 diabetes, and an unprocessed sexuality crisis centered on his feelings for Charlie Rivera.

Presentation: Logan's stress-induced migraines typically manifested with severe nausea and vomiting—he vomited after his December 10, 2025 epigenetics presentation, vomited during study sessions, and experienced migraine-induced nausea that combined with the physical effects of blood sugar instability. The vomiting pattern was significant enough that his roommate Marcus Dupree spent time on the bathroom floor with him during the worst episodes, and Charlie Rivera monitored the escalation through phone calls from Juilliard.

Interaction with Type 1 Diabetes: The relationship between Logan's migraines and his diabetes management created a dangerous feedback loop. Stress triggered migraines and nausea, which disrupted eating patterns and blood sugar stability, which in turn worsened the stress response and made migraines more frequent. His Dexcom readings became increasingly erratic as the semester progressed, and during his December 7 panic attack call to Charlie, his blood sugar dropped to 48 mg/dL—a dangerously hypoglycemic level that compounded the migraine and emotional crisis.

Long-Term Significance: While Logan's migraines are not as frequent or disabling as Jacob Keller's chronic migraine pattern, they represent a significant component of the mind-body connection that defined his approach to medicine. His personal experience of stress-induced neurological symptoms informed his later clinical work at the Weston Centers, particularly his understanding of how psychological stress manifests as physical illness and how the medical establishment often fails to address the whole patient.

Representation Significance: Logan's stress-induced migraines illustrate how Black men's neurological symptoms are often dismissed or attributed to "not handling stress well" rather than recognized as legitimate medical conditions requiring intervention. His pattern of ignoring symptoms to maintain performance—ignoring Dexcom alarms during presentations, pushing through migraines to attend study groups, refusing to acknowledge his body's signals—reflects both the "Weston Double" and the broader cultural pressure on Black men to perform excellence without acknowledging vulnerability.


FOR CHARACTER DEVELOPMENT

Writing Characters with Migraine

Avoid These Stereotypes: - Migraine is just an excuse to get out of something - Can "push through" if they really wanted to - Exaggerating for attention - "Tough" characters don't get migraines - Only affects "weak" or "neurotic" people - Just take aspirin and it goes away - Only triggered by stress or worry

More Realistic Portrayals: - Unpredictability causes anxiety and affects planning - Invisible disability—character looks fine between attacks - Impact on work, relationships, hobbies - Frustration with limitations and lost time - Medication decisions (side effects vs. benefit) - Trigger avoidance changes daily life - Guilt about impact on others - Struggle to be taken seriously

Physical Details During Attack: - Holding head, pressing temples - Squinting or closing eyes (light sensitivity) - Covering ears or asking for quiet - Nausea, vomiting - Pale, sweaty, clammy - Moving slowly, carefully (movement worsens pain) - Lying still in dark room - Speaking quietly or not at all - Irritable or withdrawn

Emotional State: - Pain and frustration during attack - Relief when it ends - Anxiety about next attack - Grief over missed events - Guilt (especially parents missing children's activities) - Exhaustion during postdrome - Fear that others think they're faking - Anger at limitations

Scenarios and Conflicts

Work/School: - Missing important meeting/exam due to migraine - Coworker/teacher doesn't believe it's serious - Trying to work through attack (presenteeism) - Needing accommodations, facing pushback - Career impact of frequent absences - Having to cancel presentation or event

Relationships: - Cancelling plans last-minute - Partner frustrated by unpredictability - Sexual activity triggers migraine - Missing partner's important event - Feeling like burden - Partner taking on more responsibilities

Parenting: - Parent with migraine needing dark, quiet room - Children not understanding why parent can't play - Missing children's events (recital, game, etc.) - Guilt over impact on children - Needing other parent or caregiver to take over

Major Life Events: - Migraine on wedding day, vacation, graduation - Fear of having attack during important event - Pre-medicating preventively (with risks) - Managing triggers during stressful times - Having to leave event early

Intersectionality Considerations

Gender: - Women's migraines often dismissed as "hormonal" or "psychosomatic" - Men's migraines underdiagnosed due to "women's disease" perception - Non-binary people face unique challenges with hormonal triggers and healthcare access - Women may face pressure to "smile through" pain - Men may face pressure not to admit vulnerability

Race and Ethnicity: - Medical racism affects diagnosis and treatment - Racial disparities in pain management - Some racial groups underrepresented in migraine research - Language barriers in describing symptoms - Cultural attitudes toward pain expression

Socioeconomic Status: - Expensive medications (newer treatments) - Insurance coverage gaps - Inability to afford preventive care - Can't miss work due to financial necessity - Limited access to specialists - Food insecurity affects trigger management

Disability: - Migraine as disability in itself - Comorbid conditions complicating management - Multiple medications, interactions - Difficulty accessing healthcare - Invisible disability doubted by others - Impact on other conditions

Age: - Children with migraine often dismissed - Adolescent girls facing hormonal triggers - College students managing migraines independently - Working-age adults balancing career and health - Older adults with comorbid conditions - Age-related changes in migraine patterns

Character Arcs and Growth

Possible Storylines: - Learning to accept limitations and ask for help - Finding effective treatment after years of suffering - Advocating for accommodations despite disbelief - Relationship strain and eventual understanding - Career changes due to disability - Finding community with other chronic pain patients - Grief and acceptance of chronic condition - Learning to live fully despite unpredictability - Standing up to medical dismissal - Educating others about invisible disability


HISTORICAL CONTEXT AND MEDICAL EVOLUTION

Ancient and Pre-Modern Understanding

Migraine is among the oldest documented medical conditions in human history. The earliest known written description appears in the Ebers Papyrus from ancient Egypt (~1550 BCE), which describes head pain accompanied by visual disturbances. Hippocrates provided what may be the first clinical description of migraine aura in the 5th century BCE, documenting shimmering light and visual phenomena preceding severe head pain. In the 2nd century CE, the Greek physician Galen coined the term "hemicrania" (literally "half head"), from which the modern word "migraine" derives, recognizing the characteristic one-sided nature of the pain.

Throughout antiquity and the medieval period, migraine was attributed variously to demonic possession, divine punishment, imbalances of bodily humors, or moral failing. Treatments ranged from trepanation (drilling holes in the skull to release evil spirits) to bloodletting to herbal remedies of varying efficacy.

19th Century: Emerging Scientific Understanding

The 19th century saw the beginning of scientific approaches to migraine. Edward Liveing's 1873 treatise "On Megrim, Sick-Headache, and Some Allied Disorders" established migraine as a legitimate medical condition with distinct phases and characteristics. However, the dominant Victorian-era belief held that migraine was a condition of the "nervous temperament"—associated with refined sensibilities, artistic genius, or emotional instability.

This period established the gendered framework that would shape migraine perception for over a century: migraine was characterized as primarily affecting women, attributed to their supposed nervous constitutions and emotional natures. Men with migraine were often considered to have feminine weakness or were diagnosed with other conditions to preserve their masculine identity.

Early 20th Century: Ergot and Early Treatments

Ergot alkaloids, derived from a fungus that grows on rye, had been used for migraine since the 17th century, but systematic study began in the early 1900s. Ergotamine tartrate was introduced in the 1920s and remained the primary acute migraine treatment for decades. While often effective, ergot preparations had significant side effects and contraindications, and their use could lead to "ergot headache"—an early recognition of what would later be called medication overuse headache.

Prevention options remained limited. Phenobarbital and other sedatives were used but carried addiction risks and cognitive effects. The general medical attitude remained that migraine was a "functional" disorder—real enough, but rooted in nervous constitution rather than organic pathology.

1960s-1980s: The Psychosomatic Era

The mid-20th century saw migraine firmly categorized as a psychosomatic condition. Freudian interpretations held that migraines represented repressed emotions, particularly anger or sexual frustration. Women's migraines were especially likely to be dismissed as "hysteria" or "neurosis," with treatment focusing on psychotherapy, sedatives, and reassurance rather than addressing the underlying neurological condition.

"Just a headache" dismissal became endemic. Patients were routinely told their pain was not real, that they were exaggerating, or that they simply needed to "relax" or "not worry so much." This era saw some of the most profound medical gaslighting of migraine patients, particularly women and those with atypical presentations like hemiplegic migraine.

Treatment options expanded modestly during this period. Beta-blockers (propranolol) were discovered to have preventive effects in the 1960s, and tricyclic antidepressants (amitriptyline) were added to the preventive arsenal. However, these were often framed as treating the "nervous" basis of migraine rather than the neurological condition itself.

1980s-1990s: The Triptan Revolution

The development of triptans represented the first migraine-specific acute treatment and marked a fundamental shift in medical understanding. The serotonin (5-HT) hypothesis emerged in the 1980s, recognizing migraine as a neurovascular disorder with specific receptor targets.

Sumatriptan, the first triptan, was developed in the mid-1980s and received FDA approval in 1992 (UK approval 1991). For the first time, patients had access to medication designed specifically for migraine mechanism rather than general pain relief. Multiple other triptans followed throughout the 1990s (rizatriptan, zolmitriptan, eletriptan, and others), offering options for patients who didn't respond to sumatriptan.

The International Classification of Headache Disorders (ICHD) was first published in 1988, establishing standardized diagnostic criteria. This represented crucial legitimization of migraine as a distinct neurological entity requiring specific diagnosis and treatment.

However, the triptan era also brought new problems. Patients with hemiplegic migraine were excluded from triptan trials and remain contraindicated for triptan use due to concerns about prolonged aura and potential stroke risk. This left patients with the most severe and frightening migraine subtype without access to the most effective acute treatments.

2000s-2010s: Recognition and Remaining Gaps

The 2000s saw continued treatment advances, including FDA approval of topiramate and other anticonvulsants for migraine prevention, and OnabotulinumtoxinA (Botox) approval for chronic migraine in 2010. Migraine was increasingly recognized as a major public health burden—the World Health Organization ranked it as the second leading cause of years lived with disability globally.

Yet significant gaps remained. The average delay to proper diagnosis remained 5-7 years for many patients. Men with migraine continued to be underdiagnosed due to the persistent perception of migraine as a "women's condition." Racial disparities in diagnosis and treatment were documented, with Black and Hispanic patients less likely to receive accurate diagnosis and effective treatment.

2018-Present: CGRP Era and Ongoing Evolution

The approval of CGRP (calcitonin gene-related peptide) monoclonal antibodies beginning in 2018 represented another major advance—the first preventive medications developed specifically for migraine mechanism. Erenumab, fremanezumab, galcanezumab, and eptinezumab offered new options for patients who hadn't responded to older preventives.

Gepants (small molecule CGRP receptor antagonists) were approved for both acute and preventive use, offering alternatives for patients who cannot take triptans. Neuromodulation devices received FDA approval. The medical community increasingly recognized migraine as a serious, disabling neurological disease requiring specialized care.

Despite advances, challenges persist: many newer treatments are expensive and insurance coverage varies; many patients still face "just a headache" dismissal; underdiagnosis in men and minorities continues; and patients with rare subtypes like hemiplegic migraine remain underserved by research and treatment development.

Stigma and the "Just a Headache" Problem

The persistent minimization of migraine as "just a headache" represents one of the most enduring forms of medical gaslighting. This dismissal has roots in the gendered history of the condition (associated with women, therefore not serious), the invisible nature of the disability (patients often "look fine" between attacks), and the episodic pattern (periods of wellness between attacks suggest the condition can't be that bad).

The "just a headache" framework causes real harm: delayed diagnosis, inadequate treatment, workplace discrimination, relationship strain, and internalized shame. Patients learn to minimize their own suffering, to push through when they shouldn't, and to doubt their own experiences. The phrase itself reveals how little the speaker understands about migraine—a condition that involves not just pain but nausea, vomiting, sensory hypersensitivity, cognitive impairment, and days of lost functioning.

Era-Specific Character Implications

Tommy Hayes (Born 1954; First Episode 1969): Tommy's hemiplegic migraine journey represents the worst of the psychosomatic era. When his first episode occurred at age 15 in 1969—with left-sided weakness, slurred speech, and severe headache—the medical understanding of hemiplegic migraine was minimal. His symptoms mimicked stroke so closely that proper diagnosis was nearly impossible without modern imaging and a medical community familiar with the condition.

For 28 years (1969-1997), Tommy experienced recurrent episodes without proper diagnosis or treatment. The 1970s-1980s psychosomatic framework meant his symptoms were attributed to stress, anxiety, or "dramatics." His spouse dismissed his episodes as "faking" or attention-seeking for two decades. Medical professionals told him it was "all in his head"—ironic for a neurological condition affecting his brain. The triptans developed in the 1990s were contraindicated for hemiplegic migraine even had he been diagnosed, leaving him with only OTC pain relievers and endurance.

His 1997 diagnosis (age 43) came after a severe episode prompted neurological workup. By then, he had internalized decades of dismissal, believing himself "weak" for being affected by something everyone told him wasn't real. The proper diagnosis came too late to undo the damage to his self-concept, his marriage, or his lost years of effective treatment.

Jacob Keller (Born 2007; Chronic Migraine): Jacob's experience with chronic migraine (15-20 days per month, 6-10 requiring ER visits for IV fluids) occurs in a modern medical era with vastly improved treatment options—CGRP medications, Botox for chronic migraine, multiple triptan options, and recognized status as legitimate disability. His migraine management benefits from this progress.

However, his complex comorbidities (epilepsy, bipolar disorder, autism) complicate treatment. Medication interactions must be carefully considered. His sensory sensitivities from autism may amplify migraine triggers. The medical system, even in the modern era, struggles to treat patients with multiple overlapping neurological conditions. Jacob's experience demonstrates that while treatment has improved dramatically, living with severe chronic migraine remains profoundly disabling.

Logan Weston (Born 2007; Stress-Induced Migraines): Logan's stress-induced migraines during his Howard University years (2025 and beyond) occur in the post-CGRP era of improved recognition, yet his experience illustrates how Black men's migraines remain underdiagnosed and undertreated. The cultural pressure to perform excellence, to never show weakness, to push through—combined with the historical underdiagnosis of migraine in men generally and Black patients specifically—shaped his approach to his own symptoms.

His pattern of ignoring symptoms to maintain performance, of framing migraine-induced vomiting as stress response rather than neurological event, reflects both personal perfectionism and broader cultural/medical failures. His later career as a pain specialist was informed by his own experience of having neurological symptoms dismissed or attributed to "not handling stress well."

Tyrone Morgan: Tyrone's migraine experience must be understood in the context of how Black men's pain has historically been dismissed by the medical system. The intersection of "migraines are a women's condition" dismissal and medical racism creates particular barriers to diagnosis and treatment.


RESOURCES FOR FURTHER RESEARCH

Medical Organizations

  • American Migraine Foundation
  • National Headache Foundation
  • International Headache Society
  • Migraine Research Foundation
  • European Headache Federation

Patient Communities

  • Migraine.com
  • The Migraine Support Group (online communities)
  • Local support groups through hospitals
  • Social media communities (#MigraineAwareness)

Healthcare Providers

  • Neurologists (especially headache specialists)
  • Headache centers/clinics
  • Primary care physicians
  • Pain management specialists

This reference document compiled from medical research, clinical guidelines, and patient experiences. For character development, remember that migraine is a real, disabling neurological disease—not a plot device or excuse. People with migraine deserve accurate, compassionate representation.

Last Updated: November 3, 2025

Updated 11-03-2025 from systematic review of ChatGPT chat log "Jacob Struggle with Intimacy.md": Added CHARACTER-SPECIFIC EXPERIENCES IN FAULTLINES SERIES section with comprehensive coverage of Jacob Keller's chronic migraine presentation (15-20 migraine days per month, 6-10 requiring ER visits for IV fluids).

Living Document: Medical Reference


Medical Conditions Neurological Conditions Chronic Conditions Invisible Disabilities